Fed. Circ. Revives Opana Patent Axed As Natural Law
The Federal Circuit on Thursday reversed a lower court's decision that a patent on Endo Pharmaceuticals' painkiller Opana ER is invalid for claiming nothing more than a natural law, ruling that...To view the full article, register now.
Already a subscriber? Click here to view full article